SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-19-047780
Filing Date
2019-02-22
Accepted
2019-02-22 08:47:15
Documents
77
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-K d697177d10k.htm 10-K 1161262
2 EX-3.6 d697177dex36.htm EX-3.6 4460
3 EX-23.1 d697177dex231.htm EX-23.1 3257
4 EX-31.1 d697177dex311.htm EX-31.1 11593
5 EX-31.2 d697177dex312.htm EX-31.2 11467
6 EX-32.1 d697177dex321.htm EX-32.1 6284
13 GRAPHIC g697177g16u15.jpg GRAPHIC 92236
  Complete submission text file 0001193125-19-047780.txt   7673624

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT hrtx-20181231.xml EX-101.INS 1954541
8 XBRL TAXONOMY EXTENSION SCHEMA hrtx-20181231.xsd EX-101.SCH 62072
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE hrtx-20181231_cal.xml EX-101.CAL 53739
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE hrtx-20181231_def.xml EX-101.DEF 433382
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE hrtx-20181231_lab.xml EX-101.LAB 411126
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hrtx-20181231_pre.xml EX-101.PRE 467658
Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 8582514400
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

IRS No.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33221 | Film No.: 19624046
SIC: 2834 Pharmaceutical Preparations